SYBLEU INC (SYBE)

USD 0.06

(34.15%)

Revenue Summary of SYBLEU INC

  • SYBLEU INC's latest annual revenue in 2022 was 11.69 Thousand USD , down -0.03% from previous year.
  • SYBLEU INC's latest quarterly revenue in 2023 Q4 was 2949.00 USD , down 0.0% from previous quarter.
  • SYBLEU INC reported a annual revenue of 11.7 Thousand USD in annual revenue 2021, up 188.75% from previous year.
  • SYBLEU INC reported a annual revenue of 4052.00 USD in annual revenue 2020, down 0.0% from previous year.
  • SYBLEU INC reported a quarterly revenue of 2949.00 USD for 2023 Q3, up 1.13% from previous quarter.
  • SYBLEU INC reported a quarterly revenue of 2949.00 USD for 2023 Q4, down 0.0% from previous quarter.

Annual Revenue Chart of SYBLEU INC (2022 - 2019)

Historical Annual Revenue of SYBLEU INC (2022 - 2019)

Year Revenue Revenue Growth
2022 11.69 Thousand USD -0.03%
2021 11.7 Thousand USD 188.75%
2020 4052.00 USD 0.0%
2019 - USD 0.0%

Peer Revenue Comparison of SYBLEU INC

Name Revenue Revenue Difference
Burzynski Research Institute, Inc. - USD -Infinity%
Arch Therapeutics, Inc. 75.72 Thousand USD 84.554%
Evofem Biosciences, Inc. 18.21 Million USD 99.936%
Nascent Biotech, Inc. - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
Santhera Pharmaceuticals Holding AG 122.95 Million USD 99.99%
Qrons Inc. - USD -Infinity%
Adynxx, Inc. - USD -Infinity%
Neon Bloom, Inc. - USD -Infinity%
Northwest Biotherapeutics, Inc. 1.93 Million USD 99.395%
ProtoKinetix, Incorporated - USD -Infinity%
Skye Bioscience, Inc. - USD -Infinity%
Eiger BioPharmaceuticals, Inc. 15.77 Million USD 99.926%
Nanobac Pharmaceuticals, Incorporated 17.62 Thousand USD 33.625%
Institute of Biomedical Research Corp. - USD -Infinity%
SQZ Biotechnologies Company 21.47 Million USD 99.946%
Intellipharmaceutics International Inc. 65.72 Thousand USD 82.205%
Propanc Biopharma, Inc. - USD -Infinity%
Mesoblast Limited 5.9 Million USD 99.802%
Marizyme, Inc. 645.81 Thousand USD 98.189%
Genus plc 668.8 Million USD 99.998%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
Pharming Group N.V. 245.31 Million USD 99.995%
Therapeutic Solutions International, Inc. 98.99 Thousand USD 88.185%
CNBX Pharmaceuticals Inc. 410.16 Thousand USD 97.148%
Nymox Pharmaceutical Corporation - USD -Infinity%
ContraFect Corporation - USD -Infinity%
PsyBio Therapeutics Corp. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 76.76 Thousand USD 84.763%
IMV Inc. - USD -Infinity%
AXIM Biotechnologies, Inc. 39.51 Thousand USD 70.403%
MultiCell Technologies, Inc. 49.32 USD -23614.517%
ONE Bio Corp. 52.29 Million USD 99.978%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 49.72 Million USD 99.976%
Arno Therapeutics, Inc. - USD -Infinity%
EV Biologics, Inc. 48.9 Thousand USD 76.082%
Q BioMed Inc. 284.35 Thousand USD 95.887%
Emmaus Life Sciences, Inc. 29.59 Million USD 99.96%
Mosaic ImmunoEngineering Inc. - USD -Infinity%
Biomind Labs Inc. - USD -Infinity%
American Oriental Bioengineering, Inc. 145.09 Million USD 99.992%
Provectus Biopharmaceuticals, Inc. 557.71 Thousand USD 97.903%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Oncotelic Therapeutics, Inc. 70 Thousand USD 83.291%
GlobeStar Therapeutics Corporation - USD -Infinity%
THC Farmaceuticals, Inc. - USD -Infinity%
Acro Biomedical Co., Ltd. 658.5 Thousand USD 98.224%
Curative Biotechnology, Inc. - USD -Infinity%
GB Sciences, Inc. - USD -Infinity%
Alpha Cognition Inc. - USD -Infinity%
HST Global, Inc. - USD -Infinity%
CSL Limited 14.69 Billion USD 100.0%
Wesana Health Holdings Inc. - USD -Infinity%
Halberd Corporation 999.00 USD -1070.771%
Enzolytics Inc. 52.79 Thousand USD 77.847%
Agentix Corp. - USD -Infinity%
Resverlogix Corp. - USD -Infinity%
Nuo Therapeutics, Inc. 608.52 Thousand USD 98.078%
MetaStat, Inc. - USD -Infinity%
argenx SE 1.22 Billion USD 99.999%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Endonovo Therapeutics, Inc. 140.24 Thousand USD 91.66%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. 617.38 Thousand USD 98.106%
Zenith Capital Corp. - USD -Infinity%
Genscript Biotech Corporation 839.52 Million USD 99.999%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. - USD -Infinity%
WPD Pharmaceuticals Inc. - USD -Infinity%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
Kadimastem Ltd - USD -Infinity%
Helix BioMedix, Inc. 997.72 Thousand USD 98.828%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Capstone Therapeutics Corp. 48.35 Million USD 99.976%
BioStem Technologies, Inc. 16.68 Million USD 99.93%
Oncology Pharma Inc. - USD -Infinity%
Reve Technologies, Inc. - USD -Infinity%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
Regen BioPharma, Inc. 236.56 Thousand USD 95.056%
Regen BioPharma, Inc. 236.56 Thousand USD 95.056%
NovAccess Global Inc. - USD -Infinity%
Affymax, Inc. 1.36 Million USD 99.146%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
Mobile Lads Corp. - USD -Infinity%
CytoDyn Inc. - USD -Infinity%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Alseres Pharmaceuticals, Inc. 473.73 Thousand USD 97.531%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. - USD -Infinity%
International Stem Cell Corporation 7.78 Million USD 99.85%
Bioxytran, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 13 Thousand USD 10.031%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. - USD -Infinity%
Neutra Corp. 39.53 Thousand USD 70.415%
Windtree Therapeutics, Inc. - USD -Infinity%
PureTech Health plc 3.33 Million USD 99.649%
Coeptis Therapeutics, Inc. - USD -Infinity%
IXICO plc 6.66 Million USD 99.825%
IntelGenx Technologies Corp. 1.03 Million USD 98.874%
Gelesis Holdings, Inc. 25.76 Million USD 99.955%
CSL Limited 14.8 Billion USD 100.0%
Cellectis S.A. 755 Thousand USD 98.451%